October 21, 2019 / 1:28 PM / a month ago

BRIEF-Crispr Therapeutics And Bayer Announce Update On Casebia Therapeutics

Oct 21 (Reuters) - CRISPR Therapeutics AG:

* CRISPR THERAPEUTICS AND BAYER ANNOUNCE AN UPDATE ON CASEBIA THERAPEUTICS

* CRISPR THERAPEUTICS - CASEBIA THERAPEUTICS, A JV BETWEEN CRISPR THERAPEUTICS AND BAYER, WOULD OPERATE UNDER DIRECT MANAGEMENT OF CRISPR THERAPEUTICS

* CRISPR THERAPEUTICS AG - CASEBIA THERAPEUTICS WOULD FOCUS ON DEVELOPMENT OF ITS LEAD PROGRAMS IN HEMOPHILIA, OPHTHALMOLOGY AND AUTOIMMUNE DISEASES

* CRISPR THERAPEUTICS AG - BAYER WILL HAVE OPT-IN RIGHTS FOR TWO OF CASEBIA THERAPEUTICS’ PRODUCTS AT IND SUBMISSION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below